A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

July 24, 2025

Study Completion Date

July 24, 2025

Conditions
Dermatitis, Atopic
Interventions
DRUG

GSK1070806

GSK1070806 will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (92)

1510

GSK Investigational Site, Sofia

5500

GSK Investigational Site, Mendoza

5800

GSK Investigational Site, Pleven

7099

GSK Investigational Site, Panama City

10034

GSK Investigational Site, Prague

10075

GSK Investigational Site, New York

10330

GSK Investigational Site, Bangkok

10789

GSK Investigational Site, Berlin

12120

GSK Investigational Site, Pathum Thani

14004

GSK Investigational Site, Córdoba

15355

GSK Investigational Site, Ansan

17019

GSK Investigational Site, La Rochelle

18016

GSK Investigational Site, Granada

22391

GSK Investigational Site, Hamburg

24105

GSK Investigational Site, Kiel

28222

GSK Investigational Site, Madrid

30214

GSK Investigational Site, Fayetteville

31000

GSK Investigational Site, Chihuahua City

31792

GSK Investigational Site, Thomasville

33033

GSK Investigational Site, Homestead

33334

GSK Investigational Site, Pompano Beach

34000

GSK Investigational Site, Durango

36206

GSK Investigational Site, Vigo

40138

GSK Investigational Site, Bologna

41124

GSK Investigational Site, Modena

43016

GSK Investigational Site, Dublin

44628

GSK Investigational Site, Guadalajara

45147

GSK Investigational Site, Essen

48084

GSK Investigational Site, Troy

48149

GSK Investigational Site, Münster

50009

GSK Investigational Site, Zaragoza

60614

GSK Investigational Site, Chicago

64718

GSK Investigational Site, Monterrey

70124

GSK Investigational Site, Bari

72117

GSK Investigational Site, North Little Rock

75475

GSK Investigational Site, Paris

78746

GSK Investigational Site, Austin

85006

GSK Investigational Site, Phoenix

90404

GSK Investigational Site, Santa Monica

91303

GSK Investigational Site, Canoga Park

91325

GSK Investigational Site, Northridge

92056

GSK Investigational Site, Oceanside

92708

GSK Investigational Site, Fountain Valley

100044

GSK Investigational Site, Beijing

200025

GSK Investigational Site, Shanghai

310006

GSK Investigational Site, Hangzhou

322000

GSK Investigational Site, Yiwu

350014

GSK Investigational Site, Fuzhou

400016

GSK Investigational Site, Chongqing

10029-6501

GSK Investigational Site, New York

C1055AAO

GSK Investigational Site, Buenos Aires

C1181ACH

GSK Investigational Site, Capital Federal

C1056ABI

GSK Investigational Site, Ciudad Autonoma de Bueno

X5000AAW

GSK Investigational Site, Córdoba

S2002

GSK Investigational Site, Rosario

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Guangzhou

GSK Investigational Site, Shanghai

GSK Investigational Site, Yinchuan

GSK Investigational Site, Prague

GSK Investigational Site, Athens

GSK Investigational Site, Florence

V1Y 4N7

GSK Investigational Site, Kelowna

L4M 7G1

GSK Investigational Site, Barrie

N6H 5L5

GSK Investigational Site, London

L3P1X2

GSK Investigational Site, Markham

G1W 4R4

GSK Investigational Site, Québec

128 08

GSK Investigational Site, Prague

06200

GSK Investigational Site, Nice

00128

GSK Investigational Site, Roma

00168

GSK Investigational Site, Roma

272-0033

GSK Investigational Site, Chiba

807-8556

GSK Investigational Site, Fukuoka

812-8582

GSK Investigational Site, Fukuoka

370-0829

GSK Investigational Site, Gunma

060-0033

GSK Investigational Site, Hokkaido

080-0013

GSK Investigational Site, Hokkaido

211-0063

GSK Investigational Site, Kanagawa

583-8588

GSK Investigational Site, Osaka

593-8324

GSK Investigational Site, Osaka

343-8555

GSK Investigational Site, Saitama

89-600

GSK Investigational Site, Chojnice

82-300

GSK Investigational Site, Elblag

40-600

GSK Investigational Site, Katowice

60-569

GSK Investigational Site, Poznan

70-332

GSK Investigational Site, Szczecin

03-291

GSK Investigational Site, Warsaw

03722

GSK Investigational Site, Seoul

04564

GSK Investigational Site, Seoul

04763

GSK Investigational Site, Seoul

150-950

GSK Investigational Site, Seoul

03010

GSK Investigational Site, Alicante

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY